In-Depth Examination Of 10 Analyst Recommendations For Moderna
In-Depth Examination Of 10 Analyst Recommendations For Moderna
對現代a的10個分析師建議進行深入探討
10 analysts have expressed a variety of opinions on Moderna (NASDAQ:MRNA) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的季度中，有10位分析師對Moderna（納斯達克: MRNA）表示了各種觀點，提供了從看好到看淡的多元化觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $147.3, a high estimate of $214.00, and a low estimate of $106.00. This current average has increased by 4.01% from the previous average price target of $141.62.
經過分析師的分析，12個月的目標價格提供了洞察力，平均目標爲147.3美元，最高估價爲214.00美元，最低估價爲106.00美元。 當前平均價值已從141.62美元的前一個平均目標上升了4.01%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
An in-depth analysis of recent analyst actions unveils how financial...
對最近分析師行動進行深...
登入免費觀看全文
登入/註冊